Cargando…

An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology

The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas system is best known for its role in genomic editing. It has also demonstrated great potential in nucleic acid biosensing. However, the specificity limitation in CRISPR/Cas has created a hurdle for its advancement. More recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Roueinfar, Mina, Templeton, Hayley N., Sheng, Julietta A., Hong, Ka Lok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839139/
https://www.ncbi.nlm.nih.gov/pubmed/35164379
http://dx.doi.org/10.3390/molecules27031114
_version_ 1784650297051709440
author Roueinfar, Mina
Templeton, Hayley N.
Sheng, Julietta A.
Hong, Ka Lok
author_facet Roueinfar, Mina
Templeton, Hayley N.
Sheng, Julietta A.
Hong, Ka Lok
author_sort Roueinfar, Mina
collection PubMed
description The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas system is best known for its role in genomic editing. It has also demonstrated great potential in nucleic acid biosensing. However, the specificity limitation in CRISPR/Cas has created a hurdle for its advancement. More recently, nucleic acid aptamers known for their high affinity and specificity properties for their targets have been integrated into CRISPR/Cas systems. This review article gives a brief overview of the aptamer and CRISPR/Cas technology and provides an updated summary and discussion on how the two distinctive nucleic acid technologies are being integrated into modern diagnostic and therapeutic applications
format Online
Article
Text
id pubmed-8839139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88391392022-02-13 An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology Roueinfar, Mina Templeton, Hayley N. Sheng, Julietta A. Hong, Ka Lok Molecules Review The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas system is best known for its role in genomic editing. It has also demonstrated great potential in nucleic acid biosensing. However, the specificity limitation in CRISPR/Cas has created a hurdle for its advancement. More recently, nucleic acid aptamers known for their high affinity and specificity properties for their targets have been integrated into CRISPR/Cas systems. This review article gives a brief overview of the aptamer and CRISPR/Cas technology and provides an updated summary and discussion on how the two distinctive nucleic acid technologies are being integrated into modern diagnostic and therapeutic applications MDPI 2022-02-07 /pmc/articles/PMC8839139/ /pubmed/35164379 http://dx.doi.org/10.3390/molecules27031114 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Roueinfar, Mina
Templeton, Hayley N.
Sheng, Julietta A.
Hong, Ka Lok
An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
title An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
title_full An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
title_fullStr An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
title_full_unstemmed An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
title_short An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
title_sort update of nucleic acids aptamers theranostic integration with crispr/cas technology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839139/
https://www.ncbi.nlm.nih.gov/pubmed/35164379
http://dx.doi.org/10.3390/molecules27031114
work_keys_str_mv AT roueinfarmina anupdateofnucleicacidsaptamerstheranosticintegrationwithcrisprcastechnology
AT templetonhayleyn anupdateofnucleicacidsaptamerstheranosticintegrationwithcrisprcastechnology
AT shengjuliettaa anupdateofnucleicacidsaptamerstheranosticintegrationwithcrisprcastechnology
AT hongkalok anupdateofnucleicacidsaptamerstheranosticintegrationwithcrisprcastechnology
AT roueinfarmina updateofnucleicacidsaptamerstheranosticintegrationwithcrisprcastechnology
AT templetonhayleyn updateofnucleicacidsaptamerstheranosticintegrationwithcrisprcastechnology
AT shengjuliettaa updateofnucleicacidsaptamerstheranosticintegrationwithcrisprcastechnology
AT hongkalok updateofnucleicacidsaptamerstheranosticintegrationwithcrisprcastechnology